NCT02592135View on ClinicalTrials.gov

High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT)

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

December 21, 2015

Primary Completion Date

November 7, 2017

Study Completion Date

May 31, 2018

Conditions
Heart Failure
Interventions
OTHER

hsTnT level

hsTnT and NTproBNP levels at baseline and baseline plus 3 hours.

Trial Locations (5)

37235

Vanderbilt University, Nashville

45220

University of Cincinnati, Cincinnati

46202

Eskenazi Health, Indianapolis

IU Health Methodist Hospital, Indianapolis

48201

Detroit Receiving Hospital, Detroit

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

collaborator

Wayne State University

OTHER

collaborator

University of Cincinnati

OTHER

lead

Indiana University

OTHER

NCT02592135 - High Sensitivity cTnT Rules Out Cardiac Insufficiency Trial (TACIT) | Biotech Hunter | Biotech Hunter